Metropolis Healthcare has announced that a board meeting is scheduled for May 13, 2026. The board will review and approve the company’s audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the directors will consider the declaration of a second interim dividend for the financial year 2025-26 to reward its shareholders.
Upcoming Board Meeting
The Board of Directors of Metropolis Healthcare is set to convene on Wednesday, May 13, 2026. The primary agenda for this meeting is the evaluation and formal approval of the company’s audited financial performance for the quarter and the full financial year concluded on March 31, 2026.
Potential Dividend Announcement
Beyond the financial results, the board will deliberate on the distribution of a second interim dividend for the 2025-26 financial year. Any decision regarding the dividend amount or record date will be finalized during this session, reflecting the company’s ongoing commitment to delivering value to its stakeholders.
Trading Window Closure
In adherence to internal corporate governance policies, the company has restricted trading in its securities. The trading window for designated persons and insiders has been closed from April 01, 2026, and will remain restricted until May 15, 2026, to ensure confidentiality ahead of the earnings release.
Source: BSE
